Claims-Recorded Comorbidities, Healthcare Utilization, Costs, and Mortality: A Retrospective Analysis of the 2025 Edition of the Indonesian National Health Insurance Contextual COVID-19 Dataset

Background: Evidence remains limited on relationships between comorbidities, healthcare utilization, costs, and mortality among Indonesian recipients of coronavirus disease 2019-related services. Aim: To examine factors associated with healthcare utilization, annualized high costs, and recorded mortality in the Indonesian National Health Insurance Contextual COVID-19 Sample. Methods: This retrospective study linked five membership and claims sources covering 2015–2024. The cohort comprised recipients of coronavirus disease 2019-related services during 2020–2023. Analyses were performed in Python 3.13 and included normalized probability-weighted logistic regression, negative-binomial regression with an observation-time offset, a two-part annual cost model, sensitivity analyses, and five-fold cross-validation. Results: The analysis included 32,243 participants; 53.3% had claims-recorded comorbidities and 19.0% had recorded deaths. Chronic kidney disease was associated with recorded mortality (adjusted odds ratio 2.56; 95% confidence interval 2.31–2.84), annualized high cost (adjusted odds ratio 6.36; 95% confidence interval 5.70–7.09), and visit rate (adjusted incidence rate ratio 2.15; 95% confidence interval 2.05–2.26). Malignancy and human immunodeficiency virus were also strongly associated with mortality and costs. The cross-validated area under the curve for mortality was 0.795. Conclusions: Claims-recorded comorbidities identified groups with substantially different healthcare utilization, annual costs, and recorded mortality. Chronic kidney disease, malignancy, and human immunodeficiency virus showed the largest adjusted associations. These findings support risk-stratified service planning but remain non-causal because diagnoses and outcomes were retrospectively accumulated.

Authors

Institutions

Publication Details

Journal
COVID
Published
2026-11-13
DOI
https://doi.org/10.3390/covid6110203
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Claims-Recorded Comorbidities, Healthcare Utilization, Costs, and Mortality: A Retrospective Analysis of the 2025 Edition of the Indonesian National Health Insurance Contextual COVID-19 Dataset

Chrismerry Song, Yohanes Firmansyah, Ronald Winardi Kartika, Donatila Mano S et al.
COVID
COVID-19 Clinical Research Studies
article

Claims-Recorded Comorbidities, Healthcare Utilization, Costs, and Mortality: A Retrospective Analysis of the 2025 Edition of the Indonesian National Health Insurance Contextual COVID-19 Dataset

Chrismerry Song, Yohanes Firmansyah, Ronald Winardi Kartika, Donatila Mano S, Wawan Kurnia, Bryan Anna Wijaya
article en

Abstract

Background: Evidence remains limited on relationships between comorbidities, healthcare utilization, costs, and mortality among Indonesian recipients of coronavirus disease 2019-related services. Aim: To examine factors associated with healthcare utilization, annualized high costs, and recorded mortality in the Indonesian National Health Insurance Contextual COVID-19 Sample. Methods: This retrospective study linked five membership and claims sources covering 2015–2024. The cohort comprised recipients of coronavirus disease 2019-related services during 2020–2023. Analyses were performed in Python 3.13 and included normalized probability-weighted logistic regression, negative-binomial regression with an observation-time offset, a two-part annual cost model, sensitivity analyses, and five-fold cross-validation. Results: The analysis included 32,243 participants; 53.3% had claims-recorded comorbidities and 19.0% had recorded deaths. Chronic kidney disease was associated with recorded mortality (adjusted odds ratio 2.56; 95% confidence interval 2.31–2.84), annualized high cost (adjusted odds ratio 6.36; 95% confidence interval 5.70–7.09), and visit rate (adjusted incidence rate ratio 2.15; 95% confidence interval 2.05–2.26). Malignancy and human immunodeficiency virus were also strongly associated with mortality and costs. The cross-validated area under the curve for mortality was 0.795. Conclusions: Claims-recorded comorbidities identified groups with substantially different healthcare utilization, annual costs, and recorded mortality. Chronic kidney disease, malignancy, and human immunodeficiency virus showed the largest adjusted associations. These findings support risk-stratified service planning but remain non-causal because diagnoses and outcomes were retrospectively accumulated.

COVIDVol. 6(11)
Tarumanagara University (ID), Krida Wacana Christian University (ID)
Good health and well-being
COVID-19 Clinical Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon